Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Recruiting · NCT07346157 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease | Medulloblastoma, Childhood, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT07346157 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sabine Mueller, MD, PhD | 7 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's National Hospital | Washington D.C. | United States | 100 |
| Seattle Children's | Seattle | United States | 21 |
| University of California, San Francisco | San Francisco | United States | 294 |